John Wiley & Sons, Inc. (NYSE:WLY – Get Free Report) announced a quarterly dividend on Thursday, December 12th,NASDAQ Dividends reports. Investors of record on Thursday, December 26th will be paid a dividend of 0.3525 per share on Thursday, January 9th. This represents a $1.41 dividend on an annualized basis and a yield of 3.08%. The ex-dividend date is Thursday, December 26th. This is a boost from John Wiley & Sons’s previous quarterly dividend of $0.35.
John Wiley & Sons has increased its dividend by an average of 0.7% annually over the last three years and has increased its dividend every year for the last 26 years. John Wiley & Sons has a dividend payout ratio of 38.1% indicating that its dividend is sufficiently covered by earnings.
John Wiley & Sons Trading Down 0.3 %
WLY stock opened at $45.84 on Friday. John Wiley & Sons has a twelve month low of $30.45 and a twelve month high of $53.96. The stock has a market capitalization of $2.48 billion, a price-to-earnings ratio of -50.37 and a beta of 0.85. The company has a quick ratio of 0.61, a current ratio of 0.66 and a debt-to-equity ratio of 1.26. The firm’s fifty day simple moving average is $50.07 and its two-hundred day simple moving average is $46.17.
Insider Activity
In other John Wiley & Sons news, EVP Danielle Mcmahan sold 2,318 shares of the firm’s stock in a transaction on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total transaction of $114,532.38. Following the transaction, the executive vice president now directly owns 8,978 shares in the company, valued at $443,602.98. This trade represents a 20.52 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.62% of the company’s stock.
John Wiley & Sons Company Profile
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
Read More
- Five stocks we like better than John Wiley & Sons
- What Investors Need to Know to Beat the Market
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Are the FAANG Stocks and Are They Good Investments?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Low PE Growth Stocks: Unlocking Investment Opportunities
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.